Published in PLoS One on April 16, 2012
Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity. Proc Natl Acad Sci U S A (2014) 1.45
CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals. PLoS One (2014) 0.78
Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival. Hepatol Int (2013) 0.76
Acute Simian Immunodeficiency Virus Infection Triggers Early and Transient Interleukin-7 Production in the Gut, Leading to Enhanced Local Chemokine Expression and Intestinal Immune Cell Homing. Front Immunol (2017) 0.75
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature (2005) 6.21
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol (2007) 3.53
Rare birds in North America: acute hepatitis C cohorts. Gastroenterology (2008) 3.45
Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med (2002) 3.43
HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity (2004) 2.86
Hepatic interleukin-7 expression regulates T cell responses. Immunity (2009) 2.25
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol (2009) 1.98
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS (2000) 1.97
A new standard of care for the treatment of chronic HCV infection. Nat Rev Gastroenterol Hepatol (2011) 1.91
Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol (2008) 1.90
Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood (2009) 1.89
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood (2006) 1.83
Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology (2006) 1.78
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther (2004) 1.65
Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection. Lancet (1993) 1.55
Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol (2000) 1.55
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol (2006) 1.47
T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med (2001) 1.42
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One (2009) 1.32
Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Can J Gastroenterol (2007) 1.21
Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. Clin Cancer Res (2000) 1.15
Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood (2007) 1.13
A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response. J Immunol (2004) 1.11
Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol (2007) 1.10
IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis. J Immunol (2000) 1.08
Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis. J Viral Hepat (2007) 1.04
Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol (2001) 1.00
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Infection (2008) 0.99
Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients. J Infect Dis (2002) 0.97
Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol (2006) 0.96
Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression. Cytokine (1999) 0.95
Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage. Southeast Asian J Trop Med Public Health (1999) 0.89
The magnitude of thymic output is genetically determined through controlled intrathymic precursor T cell proliferation. J Immunol (2008) 0.88
The role of interleukin-7 in early T-cell development. Leuk Lymphoma (1998) 0.87
Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis (2005) 0.87
A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment. J Immunol Methods (2009) 0.82
Future trends in managing hepatitis C. Gastroenterol Clin North Am (2004) 0.81
Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients. Lancet (1993) 0.81
CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group. AIDS (1994) 0.80
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group. J Infect (1995) 0.80
T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin. HIV Med (2003) 0.77
Endogenous interferon-alpha production by differentiating human monocytes regulates expression and function of the IL-2/IL-4 receptor gamma chain. Cytokine (2002) 0.76
High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis (2007) 7.70
HCV persistence and immune evasion in the absence of memory T cell help. Science (2003) 5.23
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology (2006) 3.92
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med (2010) 3.81
HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell (2010) 3.49
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
Rare birds in North America: acute hepatitis C cohorts. Gastroenterology (2008) 3.45
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood (2004) 3.35
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14
HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity (2004) 2.86
Understanding polydrug use: review of heroin and cocaine co-use. Addiction (2003) 2.68
Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol (2007) 2.55
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology (2004) 2.44
[Time to think in new ways? Frequent suicide risk assessments can increase the danger of suicide]. Lakartidningen (2010) 2.01
Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol (2008) 1.90
Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood (2009) 1.89
Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med (2004) 1.79
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology (2013) 1.77
A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood (2013) 1.74
Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health (2005) 1.73
Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS (2008) 1.63
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend (2006) 1.51
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis (2009) 1.49
Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology (2003) 1.48
A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS (2008) 1.47
IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol (2006) 1.47
Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS (2005) 1.47
Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors. Clin Immunol (2012) 1.47
Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ (2004) 1.44
NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell (2012) 1.44
Suppression of HIV-1 replication by microRNA effectors. Retrovirology (2009) 1.44
Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest. Crit Care Med (2015) 1.39
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39
HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol (2010) 1.28
CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog (2011) 1.26
Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog (2008) 1.24
Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One (2011) 1.24
Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. Blood (2009) 1.24
Neuropilin-1 is not a marker of human Foxp3+ Treg. Eur J Immunol (2009) 1.22
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology (2007) 1.22
Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) (2004) 1.21
Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Can J Gastroenterol (2007) 1.21
In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients. Proc Natl Acad Sci U S A (2010) 1.21
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica (2010) 1.19
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol (2010) 1.15
Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion (2008) 1.11
Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection. PLoS Pathog (2013) 1.10
Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol (2007) 1.10
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood (2011) 1.09
Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog (2013) 1.09
Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients. Medicine (Baltimore) (2014) 1.08
Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. J Virol (2006) 1.05
Association between neighbourhood socioeconomic characteristics and high-risk injection behaviour amongst injection drug users living in inner and other city areas in Montréal, Canada. Int J Drug Policy (2009) 1.04
Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS One (2010) 1.04
Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection. J Virol (2008) 1.03
Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Hepatology (2010) 1.03
Polypyrrole based DNA hybridization assays: study of label free detection processes versus fluorescence on microchips. J Pharm Biomed Anal (2003) 1.02
Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J Immunol (2011) 1.02
Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur J Immunol (2004) 1.02
Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee. Hepatology (2003) 1.01
Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol (2010) 1.01
Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol (2007) 1.00
APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. AIDS (2006) 1.00
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood (2009) 0.98
Heroin and cocaine co-use in a group of injection drug users in Montréal. J Psychiatry Neurosci (2004) 0.98
Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Subst Use Misuse (2003) 0.98
Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol (2010) 0.97
DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa. J Virol (2011) 0.97
Immune response to HIV. Curr Opin HIV AIDS (2013) 0.97
The Second Canadian Symposium on hepatitis C virus: a call to action. Can J Gastroenterol (2013) 0.96
Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells. AIDS (2013) 0.96
A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials. J Acquir Immune Defic Syndr (2005) 0.95
Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci (2002) 0.94
Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users. Drug Alcohol Depend (2012) 0.93
Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood (2012) 0.93
Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. J Immunol (2009) 0.93
A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf. Eur J Med Genet (2011) 0.93
In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. Blood (2003) 0.92
Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog (2012) 0.92
HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. AIDS (2002) 0.92
Satellite needle distribution among injection drug users: policy and practice in two canadian cities. J Acquir Immune Defic Syndr (2002) 0.91